Pressmeddelande —
Affibody AB receives SwedenBIO award 2013
Solna, Sweden, May 22, 2013. Affibody wins SwedenBIO Award 2013 for its unique business model.
Affibody received the SwedenBIO Award 2013 at life sciences industry organization SwedenBIO’s annual conference in Stockholm on May 21, 2013. The award is the industry’s own award which aims to focus the attention on Swedish life science companies that have achieved significant national and international recognition during the previous year.
During 2012 Affibody took several critical steps forward and saw its revenues grow significantly. Additionally business development activities yielded two new key collaborations during the year including the company’s first clinical stage collaboration.
Commenting on the award, David Bejker, Chief Executive Officer of Affibody AB, said: “We are thrilled to win this award. It is rewarding for me and my colleagues to receive this acknowledgement for our work in the past few years. Our increasing number of collaboration partners validates our unique platforms that are products of world leading Swedish research. Looking ahead we see great opportunity to further expand our business and continue to create value from our technology platforms.”
Further information about the award can be found in the attached press release from SwedenBIO (in Swedish).
Ämnen
- Hälsa, sjukvård, läkemedel
Kategorier
- affibody
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Affibody is developing a portfolio of innovative drug projects and, in addition, offers the half-life extension technology, Albumod™, for outlicensing.
Affibody has ongoing commercial relationships with several companies including Algeta, Amylin, Sobi, GE, and Thermo Fisher.
Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute and is based in Stockholm, Sweden. Major shareholders in the Company include HealthCap and Investor AB.
Further information can be found at: www.affibody.com
